Bliss GVS Pharma Limited — Board/Management Information 2021

May 11, 2021

BLISS GVS PHARMA LTD. ca.s.s

May ll, 2021

Dear Sir/Madam,

Subject: Outcome of Board Meeting held on Tuesday, May 11, 2021

We would like to inform you that, the Board Meeting of the Company was held today i.e. Tuesday, May 11, 2021 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the following matters:

• 1. The Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2021 along with the audit report of the auditors. The copy of said financial results and audit reports are enclosed herewith as' Annexure -1';
• 1. Declaration of unmodified opinion for annual audited standalone and consolidated financial results for the year ended March 31, 2021 in accordance with Regulation 33(3)( d) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/56/2016 dated May 27, 2016 is enclosed herewith as 'Annexure - 2';
• 1. Recommended Final dividend of 50% i.e. 0.50 paisa per equity share on face value of Rs. 1/ each for the financial year ended March 31, 2021, subject to approval of the shareholders in the forthcoming Annual General Meeting of the Company;
• 1. Re-appointment of M/ s. BDO India LLP, Chartered Accountant having LLP registration no. AAB-7880 as Internal Auditor of the Company for the financial year 2021-22. The brief profile

Factory: Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL. : (+91) (22) 42160000/ 28505387 • FAX. : (+91) (22) 28563930, Email: info@blissgvs.com ·Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : factory@blissgvs.com

1. Issue & Allotment of 2,10,500 Equity Shares of face value of Rs. 1 each of the Company under 'Bliss GVS Pharma Limited-Employee Stock Option Plan 2019' ('Bliss GVS ESOP-2019') to the eligible employees under the said Plan, pursuant to exercise of stock options granted thereunder.

Consequent to the aforesaid allotment, Issued, subscribed & paid-up share capital of the Company has increased as under:

From	To
10,31,46,672 equity shares of Re.1 each	10,33,57,172 equity shares of Re.l each
aggregating Rs. 10,31,46,672/-	aggregating Rs. 10,33,57,172 / -

In terms of Regulation lO(c) of the SEBI (Share Based Employee Benefits) Regulations, 2014 (SEBI SBEB Regulations) read with SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015 the details of shares allotted as above are given in' Annexure-4';

• 1. Re-appointment of Mr. Santosh Laxman Parab (DIN:01622988), as an Non-Executive Independent Director of the Company for a further period of 5 years with effect from 26th May, 2021 to 25th May, 2026, subject to the approval of members in the ensuing Annual General Meeting. The brief profile of Mr. Santosh Laxman Parab is enclosed herewith as 'Annexure-5';
• 1. Resignation of Mr.SN Kama th from the position of Managing Director as well as membership from all conunittees of board of the Company with inunediate effect i.e. May 11, 2021;
• 1. Appointment of Mr. Gagan Harsh Sharma (DIN:07939421) as Managing Director of the Company for a period of Three years with effect from 11th May, 2021 to 10th May, 2024, subject to the approval of members in the ensuing Annual General Meeting. The brief profile is enclosed herewith as' Annexure-6'.
• 1. The Board reconstituted the following conunittees:
• a. Audit Committee
• b. Corporate Social Responsibility Committee

The Reconstitution is enclosed herewith as' Annexure -7'.

Regd. Office : 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072, INDIA. TEL.: (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: info@blissgvs.com •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Factory : Plot No. 1 O & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257. • Email : factory@blissgvs.com

BLISS GVS PHARMA LTD.

The meeting of the Board of Directors conunenced at 12:30 p.m. and concluded at 07:20 p.m. Kindly take the above information on your record and acknowledge.

Thanking you.

Your Faithfully,

Encl: As abov For Bliss GV Pharma Limited

Factory: Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East}, Mumbai - 400 072, INDIA. TEL.: (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: info@blissgvs.com •Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tai. & Dist. Palghar - 401 404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525} 255257. • Email :·factory@blissgvs.com

'Annexure - 5'

Brief Profile of Mr. Santosh Parab

Name of Director	Mr. Santosh Laxman Parab (DIN: 01622988)
Brief Profile	Mr. Santosh Lax man Parab Well-Known Chartered is a Accountant having Expertise in Accounts and Taxation.
Reason for change	Re-appointment
Date of appointment &	Re-appointment of Mr. Santosh Laxman Parab (DIN: 01622988) as
term of appointment	an Independent Director of the Company for the further period of Five years i.e. from 26th May, 2021 to 25th May, 2026.
Disclosure of relationships	Mr. Santosh Laxman Parab is not related to any of the Directors,
between directors	Key Managerial Personnel, Promoters and Promoter group of the Company.

'Annexure - 6'

Brief Profile of Mr. Gagan Harsh Sharma

Particulars		Appointment
Date	of	Appointment of Mr. Gagan Harsh Sharma (DIN: 07939421) as an
appointment	&	Managing Director of the Company for a period of Three years with
Te1m	of	effect from 11th May, 2021 to 10th May, 2024.
appointment
Brief Profile		Mr. Gagan Harsh Sharma, aged 38 years, having total 16 years of experience out of which 12 years of experience is with Pharma Industry. He is currently designated as Executive Director of the Company. Brief profile summary: Managed and drove multiple Mergers & Acquisitions with varying • degree of participation from initial Due Diligence to handling acute legal issues Research Development function(s) creation • Successful of & focussing on NDDS with strong focus on product pipeline for the EU /US markets developing deploying strategic client and • Proficiency m relationship management models across emerging and developed markets Expertise in managing end to end of pharrna formulation capex • projects Expert in Lean Manufacturing techniques across dosage forms like • oral solids, semi solids and injectables with special focus on niche products Build teams & capabilities to manage GMP /Regulatory compliance • addressing evolving compliance needs while ever for the formulations business Skilled in adopting & applying quality techniques & standards to • varied business processes to develop organization wide culture of quality Hands-on experience in developing HR Capabilities among large • teams; adept in deploying best in class HR practices for continual improvement Strong Focus on building brands and sustainable revenue streams • with clear focus on the bottom line
Disclosure	of	Mr. Gagan Harsh Sharma is related to Promoter & Director of the
relationships between directors		Company in the following manner: Spouse of Dr. Vibha Sharma, Whole Time Director of the
		1. Company
		Son in law of Mr. S. N. Karnath, Promoter of the Company & 2.
		Brother in Law of Mrs. Shruti Rao, Whole Time Director of the 3.
		Company.